SEC Filings

Form Description Filing date View
D View HTML
D View HTML
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

View HTML
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

View HTML
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

View HTML
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

View HTML

About us

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

 

Our Pipeline